Uterine Cancer Diagnostics Market Review 2018-2023 and Forecast to 2030: Total Revenues to Grow at a CAGR of 9%
26. Dezember 2024 04:18 ET
|
Research and Markets
Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Uterine Cancer Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Bladder Cancer Detection Kit Market to Hit USD 2.99 Billion by 2032, Driven by Advancements in Non-Invasive Technologies | Research by SNS Insider
12. Dezember 2024 07:27 ET
|
SNS Insider pvt ltd
Austin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Bladder Cancer Detection Kit Market Size & Growth Analysis: “According to SNS Insider, The Bladder Cancer Detection Kit Market Size was valued at USD...
Prostate Cancer Diagnostics Industry Business Report 2024 - Preliminary Test Segment is Expected to Reach US$10 Billion by 2030 with a CAGR of a 12.4%
09. Dezember 2024 09:50 ET
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Prostate Cancer Diagnostics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Prostate...
Next Generation Cancer Diagnostics Business Research Report 2024: Global Market to Reach $64.6 Billion by 2030 - Increasing Adoption in Biomarker Discovery and Targeted Therapy Expands Opportunities
27. November 2024 09:21 ET
|
Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
22. November 2024 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay
Head and Neck Cancer Diagnostics Market Research Report 2023-2030: Increasing Focus on Personalized Medicine, Targeted Therapies, Liquid Biopsy and Molecular Testing Expands Opportunities
04. November 2024 11:16 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Prostate Cancer Diagnostics Market Insights, Competitive Landscape, and Forecasts, 2030 - Advancements and Increased Awareness to Propel Growth
01. November 2024 10:20 ET
|
Research and Markets
Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Prostate Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's...
Liver Cancer Diagnostics Strategic Business Research Report 2024: Early Detection Programs and Growing Use of AI and Machine Learning in Imaging Expands Market Opportunities - Global Forecast to 2030
01. November 2024 05:15 ET
|
Research and Markets
Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Liver Cancer Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Liver...
Egypt Cancer Diagnostics Market Research 2023-2029: Partnerships with International Organizations Enhances Egypt's Cancer Diagnostic Services, Cairo Emerges as a Hub of Cancer Diagnostics
09. Oktober 2024 11:46 ET
|
Research and Markets
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Egypt Cancer Diagnostics Market, By Region, Competition, Forecast and Opportunities 2019-2029F" report has been added to ResearchAndMarkets.com's...
Companion Diagnostics Market Size Worth US$ 21.15 billion by 2032, Rising Prevalence of Cancer and Advances in Precision Medicine Drives Growth | Research by SNS Insider
09. Oktober 2024 09:00 ET
|
SNS Insider pvt ltd
Pune, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Companion Diagnostics Market Size Analysis: “According to SNS Insider Research, The Companion Diagnostics Market Size was valued at USD 7.66 Billion in 2023,...